<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/92B1EEF6-3D49-49C5-A7A5-5290AD810F6B"><gtr:id>92B1EEF6-3D49-49C5-A7A5-5290AD810F6B</gtr:id><gtr:name>University Medical Center Freiburg</gtr:name><gtr:address><gtr:line1>Robert-Koch-Str. 1</gtr:line1><gtr:postCode>D-79106</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FBB6E497-0DFD-470D-BF56-94DC9E8B68FD"><gtr:id>FBB6E497-0DFD-470D-BF56-94DC9E8B68FD</gtr:id><gtr:name>Philipps University of Marburg</gtr:name><gtr:address><gtr:line1>Phillips Universtaet Marburg</gtr:line1><gtr:line2>Beigenstrasse 10</gtr:line2><gtr:line4>Marburg</gtr:line4><gtr:postCode>D-35032</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/296E9ACC-110A-423D-8149-8E13836C235B"><gtr:id>296E9ACC-110A-423D-8149-8E13836C235B</gtr:id><gtr:name>Chinese University of Hong Kong</gtr:name><gtr:address><gtr:line1>Chinese University of Hong Kong</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/92B1EEF6-3D49-49C5-A7A5-5290AD810F6B"><gtr:id>92B1EEF6-3D49-49C5-A7A5-5290AD810F6B</gtr:id><gtr:name>University Medical Center Freiburg</gtr:name><gtr:address><gtr:line1>Robert-Koch-Str. 1</gtr:line1><gtr:postCode>D-79106</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FBB6E497-0DFD-470D-BF56-94DC9E8B68FD"><gtr:id>FBB6E497-0DFD-470D-BF56-94DC9E8B68FD</gtr:id><gtr:name>Philipps University of Marburg</gtr:name><gtr:address><gtr:line1>Phillips Universtaet Marburg</gtr:line1><gtr:line2>Beigenstrasse 10</gtr:line2><gtr:line4>Marburg</gtr:line4><gtr:postCode>D-35032</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/296E9ACC-110A-423D-8149-8E13836C235B"><gtr:id>296E9ACC-110A-423D-8149-8E13836C235B</gtr:id><gtr:name>Chinese University of Hong Kong</gtr:name><gtr:address><gtr:line1>Chinese University of Hong Kong</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FF4F8DDE-DC71-4C96-A12D-4E723F58715C"><gtr:id>FF4F8DDE-DC71-4C96-A12D-4E723F58715C</gtr:id><gtr:firstName>Ervin</gtr:firstName><gtr:surname>Fodor</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700848"><gtr:id>CF648EAB-DE48-482C-AE29-DB06846870CE</gtr:id><gtr:title>Molecular interactions between the transcriptional machinery of influenza virus and the host cell</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700848</gtr:grantReference><gtr:abstractText>The aim of our research is to understand how influenza virus, a major public health threat that can cause devastating pandemics, replicates in the human body. This is critical for the development of drugs and vaccines to prevent future pandemics.

The life cycle of the influenza virus begins when individual virus particles enter the cell lining of the respiratory tract in the human body. Inside the cells the genetic material of the virus is copied by a viral enzyme, the RNA polymerase. The new copies of the genetic information are then used to build new virus particles which are released from the cells to complete the life cycle.

The principal focus of our studies is to understand how the RNA polymerase is synthesized, transported and assembled in cells and which cellular components interact with it to regulate its activity. We have already discovered several of these interacting factors and now we are working to gain a more detailed understanding of the effects that these interactions have on viral replication and on the host cell. We are hoping that a better understanding of these processes will lead to the design of specific antiviral drugs that inhibit the RNA polymerase and thus viral replication.</gtr:abstractText><gtr:technicalSummary>The principal aim of the proposed research is to determine the molecular interactions between the influenza virus transcriptional machinery and the host cell and to evaluate the functional significance of these interactions during the viral life cycle. The viral RNA-dependent RNA polymerase transcribes the influenza virus vRNA genome into mRNA, and replicates it via a complementary cRNA intermediate. Although it is known that these processes take place in the nucleus of infected cells, the regulation of synthesis of these RNA products during the viral life cycle remains poorly understood. There is emerging evidence that the viral RNA polymerase functions as a pathogenicity factor, plays a role in host range restriction, and may mediate the adaptation of avian influenza viruses to mammalian hosts. These findings suggest that the activity of the viral RNA polymerase in vivo is regulated by factors specific to the host. In studies supported by my current MRC fellowship we have identified numerous cellular components that interact with the viral RNA polymerase, e.g., chaperones, import factors, and the host RNA polymerase II machinery. The key objectives of this proposal are to determine the role of these host factors and to search for others that may interact with the viral transcriptional machinery. Specifically, we aim to identify host proteins which play a role in polymerase protein folding, nuclear transport, assembly, transcriptional and replicative activity, as well as in viral RNA processing and viral mRNP assembly, transport, and translation. We are also interested in identifying and characterizing host factors that determine species specificity and pathogenicity of influenza viruses. In order to address these complex questions, we will use a combination of biochemical, proteomics and bio-imaging techniques. These studies are expected to lead to a better understanding of transmissibility of avian influenza viruses to humans, and could also help determine when an avian strain has the potential to cause an influenza pandemic in humans. Although the principal aim of this project is to further our knowledge in primary influenza research, it is also medically relevant. The RNA polymerase contains several active sites and therefore represents an ideal target for interfering with the replication cycle of the virus. Understanding of the molecular details of the interaction between the viral RNA polymerase complex and the host could lead to new ways of interfering with the activity of the viral polymerase by providing a strategy for rational drug design.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1053368</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>London Research Institute</gtr:description><gtr:id>52727EFC-3D6A-4585-A15B-C3424C463D85</gtr:id><gtr:impact>20144762</gtr:impact><gtr:outcomeId>FqS3myYB32a-1</gtr:outcomeId><gtr:partnerContribution>They introduced me to innate immunity which triggered my interest in understanding the contribution of the influenza virus RNA polymerase to the regulation of innate immune pathways in influenza virus infected cells.</gtr:partnerContribution><gtr:piContribution>We provided reagents and expertise in the functional analysis of the influenza virus RNA polymerase.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Pasteur Institute Paris</gtr:description><gtr:id>0BCAC196-556E-4E04-9A4A-46B30615FBF9</gtr:id><gtr:impact>2141153</gtr:impact><gtr:outcomeId>Qz1Vhm3mhXt-1</gtr:outcomeId><gtr:partnerContribution>Provided results and reagents for a joint publication.</gtr:partnerContribution><gtr:piContribution>We contributed results to a joint publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Chinese Academy of Sciences</gtr:description><gtr:id>33AFA14A-68FE-4B93-ADF8-E97136454B91</gtr:id><gtr:impact>19194458</gtr:impact><gtr:outcomeId>C9FDF50F1A9-1</gtr:outcomeId><gtr:partnerContribution>Provided structural information of the influenza virus RNA polymerase that underpins some of the current research in my laboratory.</gtr:partnerContribution><gtr:piContribution>The Chinese partner obtained high resolution structural information on a fragment of the PA subunit of the influenza virus RNA polymerase complex. My group contributed functional analysis of this fragment by providing experimental data that the studied fragment of PA contains an endonuclease domain.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NIH</gtr:description><gtr:id>56D9154E-F830-42AA-9C6A-C691A08991B8</gtr:id><gtr:impact>19875144, 20538852, 20573828</gtr:impact><gtr:outcomeId>E21E068FCA4-1</gtr:outcomeId><gtr:partnerContribution>Partner at the NIH provided expertise in animal models for studying influenza virus pathogenicity.</gtr:partnerContribution><gtr:piContribution>Provided expertise in influenza virus molecular biology; especially in terms of RNA polymerase functional assays.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Association</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Heinrich Pette Institute, Leibniz Institute for Experimental Virology</gtr:department><gtr:description>Heinrich Pette Institute</gtr:description><gtr:id>C670346C-F7F1-431D-82DA-DABD0704C50D</gtr:id><gtr:impact>This collaboration will result in elucidating the role of importin alpha isoforms in the replication cycle of influenza virus. Adaptation to importin alpha isoforms appears to be an important factor in the crossing of influenza viruses the species barrier; i.e. the adaptation process of avian influenza viruses to humans.</gtr:impact><gtr:outcomeId>Edb5ADdRggJ-1</gtr:outcomeId><gtr:partnerContribution>Our partners provide expertise and animal models to investigate the role of importin alpha isoforms in the replication cycle of influenza virus.</gtr:partnerContribution><gtr:piContribution>We provide expertise and technology to investigate the role of importin alpha isoforms in the replication cycle of influenza virus.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>EM structural studies</gtr:description><gtr:id>4059643B-090B-4A09-9073-21AE69389F7B</gtr:id><gtr:impact>24155385</gtr:impact><gtr:outcomeId>cVQ233sRrLZ-1</gtr:outcomeId><gtr:partnerContribution>The partner provided expertise, data analysis and access to equipment to perform structural analysis by electron microscopy.</gtr:partnerContribution><gtr:piContribution>We provided material for structural studies using electron microscopy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Philipp University of Marburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Virology Marburg</gtr:department><gtr:description>University of Marburg</gtr:description><gtr:id>1B2B809A-1CDA-44D3-A0C4-953FA6748D5C</gtr:id><gtr:impact>21245837</gtr:impact><gtr:outcomeId>ovHoH5YCcEM-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise and facilities for performing experiments with highly pathogenic avian influenza viruses.</gtr:partnerContribution><gtr:piContribution>We provided expertise in the molecular and cell biology of influenza virus, in particular in the analysis of the functionality of the viral RNA polymerase.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Virology</gtr:department><gtr:description>University of Freiburg</gtr:description><gtr:id>4D52C07A-0021-4148-9218-2D656FC5D9A3</gtr:id><gtr:impact>2141153</gtr:impact><gtr:outcomeId>e2jDyKefSY4-1</gtr:outcomeId><gtr:partnerContribution>Provided results to a joint publication.</gtr:partnerContribution><gtr:piContribution>We provided results to a joint publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Single molecule studies</gtr:description><gtr:id>5BD56FEC-B0BC-49FC-81FB-3114A8DC32F3</gtr:id><gtr:impact>Multi-disciplinary collaboration: molecular biology, virology and physics</gtr:impact><gtr:outcomeId>h6Tj6zG6dML-1</gtr:outcomeId><gtr:partnerContribution>The partner contributed technology to analyse protein-RNA complexes at the single molecule level.</gtr:partnerContribution><gtr:piContribution>We provided materials for investigating influenza virus RNA polymerase - promoter interactions at the single molecule level.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:department>School of Life Sciences</gtr:department><gtr:description>Chinese University of Hong Kong</gtr:description><gtr:id>BE8706B4-89EF-4305-80EF-6D94C4E5EE1F</gtr:id><gtr:impact>20463064, 21917965, 21411538</gtr:impact><gtr:outcomeId>AkyfhVgRrFt-1</gtr:outcomeId><gtr:partnerContribution>They provided structural information on the influenza virus nucleoprotein.</gtr:partnerContribution><gtr:piContribution>We provided expertise in the functional analysis in the influenza virus nucleoprotein.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Justus Liebig University Giessen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Medical Virology</gtr:department><gtr:description>University of Giessen</gtr:description><gtr:id>79657A4B-A033-401B-ADA0-01540D694533</gtr:id><gtr:impact>20739516</gtr:impact><gtr:outcomeId>kZTAAJpK42W-1</gtr:outcomeId><gtr:partnerContribution>They provided valuable tools (recombinant influenza viruses) for the analysis of the effect of the viral non-structural protein 1 (NS1) on viral replication.</gtr:partnerContribution><gtr:piContribution>We provided expertise in the functional analysis of the influenza virus RNA polymerase.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Influenza vaccine</gtr:description><gtr:id>606D22F6-BD51-4081-9118-30D52D1760DC</gtr:id><gtr:impact>23015719</gtr:impact><gtr:outcomeId>NjZ2kTHWkHv-1</gtr:outcomeId><gtr:partnerContribution>The partner designed the vaccine and performed characterization of the vaccine in models in vitro and in vivo.</gtr:partnerContribution><gtr:piContribution>We provided a reverse genetics technology and expertise to generate recombinant influenza virus with the purpose of using this as a live attenuated influenza virus vaccine.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>University of Cambridge</gtr:description><gtr:id>8B60F47B-D76A-4295-B66E-33FD9F86996A</gtr:id><gtr:impact>19744689</gtr:impact><gtr:outcomeId>BB1B5F299A1-1</gtr:outcomeId><gtr:partnerContribution>Provided support for a model proposed for the association of the influenza virus RNA polymerase with host RNA polymerase II</gtr:partnerContribution><gtr:piContribution>Characterized and provided a mutant influenza virus RNA polymerase with reduced Pol II-binding activity to test the hypothesis that influenza virus RNA polymerase dynamics in the nucleus are affected by its association with RNA polymerase II.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Caf? Scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C68987ED-E512-4EC1-B2D5-0DCB0E6B1046</gtr:id><gtr:impact>Approximately 40 people attended a talk on human microbiota, followed by discussion.

NA</gtr:impact><gtr:outcomeId>suipx5cnB3S</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press interview (The Times)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82DE7C09-0C28-405C-911F-C1994AAF081D</gtr:id><gtr:impact>Member of the team was interviewed for a comment in an article in The Times (online edition) on a new influenza vaccine strategy.

No notable impact</gtr:impact><gtr:outcomeId>dUcbUYYvnS6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pfizer Summer School  - Canterbury</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EB7CE3A4-CB6B-4158-9691-228F3E01C418</gtr:id><gtr:impact>Lecture given to A-level students on influenza at a summer school organized by Pfizer (Biology Project Week).

Positive feedback from staff and students.</gtr:impact><gtr:outcomeId>2534AABBBCC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit (Princes Risborough Secondary School)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>326C8B95-235B-4634-A4D9-EF35B704A754</gtr:id><gtr:impact>130 pupils attended the talk on basic concepts in microbiology. including LUCA, the ubiquity of microbes, commensal microflora and the relative size of microbes, which sparked questions and discussion afterwards.

No notable impact</gtr:impact><gtr:outcomeId>sPtm85rLabe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Talk Oundle</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E5EE1CF9-B502-41DD-95E0-3F3DF9334681</gtr:id><gtr:impact>40 pupils attended a lecture on influenza viruses, followed by discussion.

NA</gtr:impact><gtr:outcomeId>jusD2Hdj4pm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxfordshire Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9ED79471-D3A5-48C2-A5E0-3FF5CC1CDC3E</gtr:id><gtr:impact>Designed, constructed and ran a hands-on demonstration on influenza virus as part of the Oxfordshire Science Festival; interacted and discussed influenza pandemics and antivirals with 200-300 people (children and adults) in Oxford town centre.

NA</gtr:impact><gtr:outcomeId>N6uirNq8hKA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Scientifique: Bacteria and Viruses</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4EB9E720-3476-4B98-B5E7-5041178E9417</gtr:id><gtr:impact>A 45 minute talk followed by 15 min questions on the microscopic life that lives on our bodies. An audience of about 40 (a mixture of school students, parents and adult members of the public) were introduced to the basic microbiology of their bodies through an interactive talk and a series of demonstrations. The training that leads up to a career in research was also discussed.

Positive response from the participants</gtr:impact><gtr:outcomeId>bJMnfrFMfwr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3662E95F-782F-42AF-840E-54B727D2515B</gtr:id><gtr:impact>Engaging in discussions with school children about science in general.

Positive feedback from schools.</gtr:impact><gtr:outcomeId>68695B920A8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>88CE2EF1-F038-4A12-8213-A542AB785980</gtr:id><gtr:impact>Engaging with school children in discussions about science in general.

A positive response from schools engaged in the activity.</gtr:impact><gtr:outcomeId>3700F912545</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Talk Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6A675137-ED9B-4A8A-9C8B-78FC28537767</gtr:id><gtr:impact>Approximately 30 people attended a talk on human microbiota, followed by discussion. The event was also podcast.

NA</gtr:impact><gtr:outcomeId>fm2hPKAL5WH</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxfordshire Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4CDAE75A-9473-4950-A474-9C016AAA1910</gtr:id><gtr:impact>An estimated 120 people (c. one group of c. 3 children and 2 adults every 10 min for 4 hours) participated in
an interactive demonstration on where new influenza viruses come from was carried out as part of the OSF launch event in Bonn Sq, central Oxford (from 12:30-4:30pm). A game involving chocolates was used to describe (i) infection (for younger participants) and (ii) the generation of 'hybrid' influenza viruses during mixed infection (for older participants). Posters, etc, showing the virus were also displayed and discussed.


Expression of interest about basic biological sciences by the public; the equipment for the stall has also been loaned out to demonstrators to help discuss influenza at an Oxford Brookes University Science Festival in September 2013.</gtr:impact><gtr:outcomeId>jwkCtWTmTe8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fourth ESWI Influenza Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B2CFEBE0-53DE-4AD7-9081-89986A6FF07B</gtr:id><gtr:impact>Fourth ESWI Influenza Conference, 11-14 September 2011, Valetta, Malta
Hutchinson EC. Interaction of the influenza A virus polymerase subunit PB1 with the host nuclear import factor RanBP5

A scientific conference attended not only by scientists, but also policy makers and health professionals with wide media coverage. Member of the team presented an invited lecture.</gtr:impact><gtr:outcomeId>bvKN81wGE49</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Abingdon School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C0C028F7-D734-43CD-A862-0756C046E9A3</gtr:id><gtr:impact>A 1h lecture on influenza, including discussion and questions, for c.40 A-level and GCSE biology students from Abingdon School and St Helen and St Katherine's School.

School asked for an annual repeat of the event.</gtr:impact><gtr:outcomeId>cZJ63dFTFgP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxfordshire Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B78CC3A0-211F-4137-8784-C3F743CA2AF7</gtr:id><gtr:impact>An interactive demonstration on where new influenza viruses come from was carried out as part of the Oxfordshire Science Festival launch event in Bonn Sq, central Oxford (from 12:30-4:30pm). A game involving chocolates was used to describe (i) infection (for younger participants) and (ii) the generation of 'hybrid' influenza viruses during mixed infection (for older participants). Posters, etc, showing the virus were also displayed and discussed.

Very positive response from the participants</gtr:impact><gtr:outcomeId>kqcCPBTvk4x</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>152000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LoLa</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J00054X/1</gtr:fundingRef><gtr:id>48C9327A-CA7E-4992-AA57-A5A4C79ACD3D</gtr:id><gtr:outcomeId>iPCS7o87iUm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1810000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K000241/1</gtr:fundingRef><gtr:id>A2D23046-C10E-4DFB-B1CA-F7F9D4314C3A</gtr:id><gtr:outcomeId>WhCaufmHs4M</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>In collaboration with the Weatherall Institute of Molecular Medicine in Oxford we have developed an attenuated influenza virus which has the potential as live attenuated vaccine.</gtr:description><gtr:id>26D0DAE9-8AC3-428F-8E88-AE0C6C25ACD9</gtr:id><gtr:impact>23015719</gtr:impact><gtr:outcomeId>nD5xyURr49W</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Live influenza virus vaccine</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:url>http://europepmc.org/abstract/MED/23015719</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a technology to specifically purify specific influenza virus RNAs from cells infected by a recombinant influenza virus expressing tagged genomic RNA.</gtr:description><gtr:id>C30B0CD4-5563-4B3D-9188-F204C22E1550</gtr:id><gtr:impact>We made this technology available to others to study virus-host cell interactions.</gtr:impact><gtr:outcomeId>KVvUqCPG8J7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RNA-tagging approach</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Influenza virus reverse genetics tools for generating fully recombinant influenza viruses for the purpose of academic research and influenza virus vaccine development. I have developed these reagents in Professor George Brownlee's laboratory (funded by an MRC programme grant) while working as a postdoctoral research assistant in his laboratory (see PMID: 10516084). After Professor Brownlee's retirement in 2008, I took over the responsibility for maintaining and developing these reagents and providing them to scientists worldwide. Annually we receive numerous requests for these reagents which we provide under an MTA.</gtr:description><gtr:id>E27655D9-41B3-4617-9FFB-D1D677B4FFF6</gtr:id><gtr:impact>The development of these research materials allowed to address numerous fundamental questions about influenza virus biology. More importantly, it resulted in the development of vaccines against seasonal flu, H5N1 viruses and the current H1N1 pandemic virus. For example, the live attenuated H1N1 pandemic vaccine produced by Medimmune was prepared by using this technology.</gtr:impact><gtr:outcomeId>EDADD378C00</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Influenza virus reverse genetics</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/10516084</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a tool to easily analyse influenza virus RNA accumulation in infected cells.</gtr:description><gtr:id>D1EB6CAE-CE89-4AE9-9882-317908DA4344</gtr:id><gtr:impact>Several collaborations with other research groups have been established.</gtr:impact><gtr:outcomeId>68F52D30330</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Analysis of influenza virus RNAs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0F980F79-8721-42F8-9681-F750BD365C02</gtr:id><gtr:title>RIG-I detects viral genomic RNA during negative-strand RNA virus infection.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>NHj3DTSw3sT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E350CBD2-8ABB-4445-80A8-423EBBF2B5BE</gtr:id><gtr:title>Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccdcc7dbf4d0863047bc18bb32e23d8"><gtr:id>6ccdcc7dbf4d0863047bc18bb32e23d8</gtr:id><gtr:otherNames>Loucaides EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>38B76E24611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6896ACD-067D-4356-BD67-55EC6C7F4D7A</gtr:id><gtr:title>Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1adea4dc168f8ad36be1faf732ada66e"><gtr:id>1adea4dc168f8ad36be1faf732ada66e</gtr:id><gtr:otherNames>Chan WH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>mpap3Doazq5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>341A3EEB-C666-4B0F-864A-8B5EEF1FF6A4</gtr:id><gtr:title>Transport of the influenza virus genome from nucleus to nucleus.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8330640dd60fadc28a48fd99b688a98"><gtr:id>c8330640dd60fadc28a48fd99b688a98</gtr:id><gtr:otherNames>Hutchinson EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_13515_25_24104053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2305B73A-869B-445B-A92F-44607B3CD8D2</gtr:id><gtr:title>NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2407fd7d5caa31c3e3af799cea483528"><gtr:id>2407fd7d5caa31c3e3af799cea483528</gtr:id><gtr:otherNames>Robb NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>F05818CF400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9054323C-FF64-4A55-B2AB-FF13FCBAF42F</gtr:id><gtr:title>Nuclear import of the influenza A virus transcriptional machinery.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8330640dd60fadc28a48fd99b688a98"><gtr:id>c8330640dd60fadc28a48fd99b688a98</gtr:id><gtr:otherNames>Hutchinson EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_13515_25_22652398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC35C5B0-CB03-4F77-AC2A-201F6F09CFA3</gtr:id><gtr:title>Influenza polymerase activity correlates with the strength of interaction between nucleoprotein and PB2 through the host-specific residue K/E627.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5dfcaf95c226b71035c0d4391fbf69a"><gtr:id>e5dfcaf95c226b71035c0d4391fbf69a</gtr:id><gtr:otherNames>Ng AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13515_25_22570712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D9581F9-200F-4D55-A7BB-846DE40A1421</gtr:id><gtr:title>The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication.</gtr:title><gtr:parentPublicationTitle>Acta virologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4042d7ca51490f6feec4d80270ef791b"><gtr:id>4042d7ca51490f6feec4d80270ef791b</gtr:id><gtr:otherNames>Fodor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-723X</gtr:issn><gtr:outcomeId>pm_13515_25_23600869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8555042D-61DB-48AD-AD50-6593F3FEA7D1</gtr:id><gtr:title>Stabilization of influenza virus replication intermediates is dependent on the RNA-binding but not the homo-oligomerization activity of the viral nucleoprotein.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f45e003a20abb4b052596af9547b5f4a"><gtr:id>f45e003a20abb4b052596af9547b5f4a</gtr:id><gtr:otherNames>Vreede FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>HdyJUagWEGc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F34A5AF7-A148-41D7-A63C-57244A0726B2</gtr:id><gtr:title>Hsp90 inhibitors reduce influenza virus replication in cell culture.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3eb69546b9ce07751799882f9d3761b"><gtr:id>f3eb69546b9ce07751799882f9d3761b</gtr:id><gtr:otherNames>Chase G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>6526A603FA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183C15CB-7D70-406D-8009-14A8034130E2</gtr:id><gtr:title>The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2407fd7d5caa31c3e3af799cea483528"><gtr:id>2407fd7d5caa31c3e3af799cea483528</gtr:id><gtr:otherNames>Robb NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>eqYM7fvQcz4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FA2A7C0-826B-495F-8A0F-BFC767C35BFA</gtr:id><gtr:title>The role of the influenza virus RNA polymerase in host shut-off.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f45e003a20abb4b052596af9547b5f4a"><gtr:id>f45e003a20abb4b052596af9547b5f4a</gtr:id><gtr:otherNames>Vreede FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>bZ6FBPr1AY3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3B14990-0BE9-4F62-A7C9-8376044091B1</gtr:id><gtr:title>Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2407fd7d5caa31c3e3af799cea483528"><gtr:id>2407fd7d5caa31c3e3af799cea483528</gtr:id><gtr:otherNames>Robb NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>QoHUvM7T61h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1095A39-233D-43B9-A2D9-ED87F8D9B036</gtr:id><gtr:title>The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2407fd7d5caa31c3e3af799cea483528"><gtr:id>2407fd7d5caa31c3e3af799cea483528</gtr:id><gtr:otherNames>Robb NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>ior43QHohPC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>164A5D8D-BDAE-48F7-BB97-F25B93BD6268</gtr:id><gtr:title>Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49da9c7bea3245dc238d7fd318a08818"><gtr:id>49da9c7bea3245dc238d7fd318a08818</gtr:id><gtr:otherNames>York A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>pm_13515_25_23807439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C15221E-3677-40BB-B8FC-522BF75E8930</gtr:id><gtr:title>Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8330640dd60fadc28a48fd99b688a98"><gtr:id>c8330640dd60fadc28a48fd99b688a98</gtr:id><gtr:otherNames>Hutchinson EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13515_25_23144613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54DBB41-DF87-450B-8E4E-B1C5A50CE7D2</gtr:id><gtr:title>Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f32d53cce90939a1c58eb3df5cfe13d8"><gtr:id>f32d53cce90939a1c58eb3df5cfe13d8</gtr:id><gtr:otherNames>Fislov? T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>keaiaUwiZE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D2B2929-A374-4A0C-B857-590FD7AE8FBD</gtr:id><gtr:title>Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8330640dd60fadc28a48fd99b688a98"><gtr:id>c8330640dd60fadc28a48fd99b688a98</gtr:id><gtr:otherNames>Hutchinson EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>mBbZrppfKvb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D8392A1-C65F-481F-9852-F7C52FA6B6A9</gtr:id><gtr:title>The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/470a1fa074c02fe01314f15ca4ececdb"><gtr:id>470a1fa074c02fe01314f15ca4ececdb</gtr:id><gtr:otherNames>Graef KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>UfRgV6jY7x6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67A414D1-16B5-404C-A490-B2B8271EFC1E</gtr:id><gtr:title>Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be9c5d18237147d2b641f0684eeaecec"><gtr:id>be9c5d18237147d2b641f0684eeaecec</gtr:id><gtr:otherNames>Yuan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>DB813B34653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2C4C262-4F78-4D8E-831A-F188A64DB0B6</gtr:id><gtr:title>Cellular cap-binding proteins associate with influenza virus mRNAs.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e71c2a9b19295f6ac38d34f0980bec7"><gtr:id>0e71c2a9b19295f6ac38d34f0980bec7</gtr:id><gtr:otherNames>Bier K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>SrcpXYntuQx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE2ACF19-2FD2-42B4-B5E1-5E276ADFED19</gtr:id><gtr:title>Emerging roles for the influenza A virus nuclear export protein (NEP).</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15edf663bb4886b402b94f84d8613224"><gtr:id>15edf663bb4886b402b94f84d8613224</gtr:id><gtr:otherNames>Paterson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13515_25_23236273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79148CFE-7370-4F11-B787-47B1B959C499</gtr:id><gtr:title>Single-molecule FRET reveals a corkscrew RNA structure for the polymerase-bound influenza virus promoter.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f112301234207b4a38cd535ba74cd3a"><gtr:id>1f112301234207b4a38cd535ba74cd3a</gtr:id><gtr:otherNames>Tomescu AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545268ae399504.67491255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC0486D-C16C-4142-AC82-D2B75B55D6BC</gtr:id><gtr:title>Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f9af1eff0083b6215f6f76b0e99a74c"><gtr:id>3f9af1eff0083b6215f6f76b0e99a74c</gtr:id><gtr:otherNames>Powell TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13515_25_23015719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C974BBA8-E146-43FC-80AC-3614B1688A1E</gtr:id><gtr:title>The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1988ca90de3863a3064fa95a5d21e5d"><gtr:id>c1988ca90de3863a3064fa95a5d21e5d</gtr:id><gtr:otherNames>Turrell L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_13515_25_23481399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A605C7BF-56F0-4814-AF10-52B7019BF051</gtr:id><gtr:title>Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f45e003a20abb4b052596af9547b5f4a"><gtr:id>f45e003a20abb4b052596af9547b5f4a</gtr:id><gtr:otherNames>Vreede FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>4924A527613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AD522EB-1F72-46DB-BD04-A05A3953E487</gtr:id><gtr:title>Isolation and characterization of the positive-sense replicative intermediate of a negative-strand RNA virus.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49da9c7bea3245dc238d7fd318a08818"><gtr:id>49da9c7bea3245dc238d7fd318a08818</gtr:id><gtr:otherNames>York A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13515_25_24145413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61EF603D-28CE-4513-9F81-F1B8CB6AFC99</gtr:id><gtr:title>Differential use of importin-a isoforms governs cell tropism and host adaptation of influenza virus.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ffda0e2f7a8333fa29eb634c4cb84ea"><gtr:id>5ffda0e2f7a8333fa29eb634c4cb84ea</gtr:id><gtr:otherNames>Gabriel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>MNypjJXn5iv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B5F651E-73C3-426B-9A6C-A6DD0DB3A1F2</gtr:id><gtr:title>Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16a3e92067207f4070e69b1efa752940"><gtr:id>16a3e92067207f4070e69b1efa752940</gtr:id><gtr:otherNames>Wise HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13515_25_23133386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>555DB971-1E27-4BFF-B3FD-D9EF877677B3</gtr:id><gtr:title>NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/904f884f2cedac3bc8311c15aeb35f7b"><gtr:id>904f884f2cedac3bc8311c15aeb35f7b</gtr:id><gtr:otherNames>Wang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>SpNQVuJSY2j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3406E48A-1AF7-43F9-A3E2-FEF0299DC694</gtr:id><gtr:title>Uncoupling of influenza A virus transcription and replication through mutation of the unpaired adenosine in the viral RNA promoter.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad8a385f93fc945bc89c63f33fc19217"><gtr:id>ad8a385f93fc945bc89c63f33fc19217</gtr:id><gtr:otherNames>te Velthuis AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13515_25_23864616</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700848</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>